Inspire Medical Systems Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for Inspire Medical Systems stock have an average target of 101.07, with a low estimate of 66 and a high estimate of 175. The average target predicts an increase of 61.82% from the current stock price of 62.46.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$66	$101.07	$91	$175
Change	+5.67%	+61.82%	+45.69%	+180.18%

Analyst Ratings

The average analyst rating for Inspire Medical Systems stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	2	3	3	3	2	2
Buy	5	6	7	6	4	4
Hold	8	5	6	7	10	10
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	14	16	16	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jonathan Block Stifel	Stifel	Strong Buy Maintains $95 → $85	Strong Buy	Maintains	$95 → $85	+36.09%	Mar 5, 2026
Mike Polark Wolfe Research	Wolfe Research	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Feb 13, 2026
Michael Sarcone Jefferies	Jefferies	Hold Maintains $81 → $66	Hold	Maintains	$81 → $66	+5.67%	Feb 12, 2026
Shagun Singh RBC Capital	RBC Capital	Hold Maintains $90 → $68	Hold	Maintains	$90 → $68	+8.87%	Feb 12, 2026
Adam Maeder Piper Sandler	Piper Sandler	Buy Maintains $165 → $85	Buy	Maintains	$165 → $85	+36.09%	Feb 12, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

988.95M

from 911.98M

8.44%

from 911.98M

Revenue Next Year

1.07B

from 988.95M

8.60%

from 988.95M

EPS This Year

1.97

from 4.89

-59.62%

from 4.89

EPS Next Year

2.59

from 1.97

30.97%

from 1.97

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	233.39M	407.86M	624.80M	802.80M	911.98M	988.95M	1.07B
Revenue Growth	102.28%	74.75%	53.19%	28.49%	13.60%	8.44%	8.60%
EPS	-1.54	-1.60	-0.72	1.75	4.89	1.97	2.59
EPS Growth	-	-	-	-	179.43%	-59.62%	30.97%
Forward PE	-	-	-	-	-	31.63	24.15
No. Analysts	-	-	-	-	-	21	20

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	1.1B	1.2B
Avg	989.0M	1.1B
Low	932.3M	980.0M

Revenue Growth

Revenue Growth	2026	2027
High	15.2%	18.5%
Avg	8.4%	8.6%
Low	2.2%	-0.9%

EPS Forecast

EPS	2026	2027
High	2.34	3.56
Avg	1.97	2.59
Low	1.38	1.58

EPS Growth

EPS Growth	2026	2027
High	-52.1%	80.3%
Avg	-59.6%	31.0%
Low	-71.7%	-20.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.